Yahoo
OTC Markets OTCPK - Delayed Quote USD

Petros Pharmaceuticals, Inc. (PTPI)

0.0020 0.0000 (0.00%)
At close: October 30 at 3:57:11 PM EDT
Chart Range Bar
Loading chart for PTPI
  • Previous Close 0.0020
  • Open 0.0020
  • Bid 0.0020 x 14182000
  • Ask 0.0024 x 8571000
  • Day's Range 0.0020 - 0.0024
  • 52 Week Range 0.0020 - 0.0240
  • Volume 64,100
  • Avg. Volume 138,038
  • Market Cap (intraday) 84,744
  • Beta (5Y Monthly) 1.88
  • PE Ratio (TTM) 0.03
  • EPS (TTM) 0.0800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

petrospharma.com

3

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PTPI
75.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

PTPI
90.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

PTPI
99.99%
S&P 500 (^GSPC)
81.91%

5-Year Return

PTPI
100.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY24
Revenue 1.58M
Earnings -5.25M
Profit Margin -332.84%

Q4

FY23

Q1

FY24

Q2

FY24

Q3

FY24

-8M
-6M
-4M
-2M
0
-500.0%
0.0%
500.0%
1000.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -38.81%

  • Return on Equity (ttm)

    -124.40%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -17.36M

  • Diluted EPS (ttm)

    0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.49M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.82M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: